Tryg A/S (0R78)
London Stock Exchange · UK · prices in DKK · close of 27 Oct 2026
Key indicators
| Last close | DKK 157.70 |
|---|---|
| 52-week range | 139.30 – 166.70 |
| Return, 1 month / 3 months | +12.8% / +2.9% |
| Return, 1 year / 3 years | +3.3% / +34.8% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 16.5% |
| Worst drawdown (1 year) | -12.2% |
| Average daily value traded | 30.86M DKK |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tryg is an insurance company based in Denmark that provides property and casualty cover to private households and businesses, mainly in the Nordic region. Its customers include individuals insuring their homes, cars and personal belongings, as well as companies seeking commercial insurance. The company also offers life and pension products in its home market. Tryg handles claims and customer service through its own organisation and distributes its policies through several channels, including partners and banks.
The shares are listed on the London Stock Exchange in UK under the code 0R78, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tryg A/S (0R78) trades on the London Stock Exchange in UK. It last closed at DKK 157.70 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 512 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.3% and over the last three months it rose 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.1% | ||
| From 52-week high | -4.8% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.9% | ||
| 6-month return | 4.6% | ||
| 12-month return, skipping the last month | -8.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.2% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 30.86M DKK | ||
| Zero-volume days | 11.7% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | +12.8% |
| 3 months | +2.9% |
| 6 months | +4.6% |
| 1 year | +3.3% |
| 3 years | +34.8% |
| 5 years | +30.4% |
Signals
| 50-day / 200-day average | 149.33 / 148.69 |
|---|---|
| Golden / death cross (60 days) | Golden, 8 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Oct 2026 | DKK 2.1500 |
| 13 Jul 2026 | DKK 2.1500 |
| 16 Apr 2026 | DKK 2.1500 |
| 23 Jan 2026 | DKK 2.0500 |
| 13 Oct 2025 | DKK 2.0500 |
| 14 Jul 2025 | DKK 2.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.